Sex differences of drug-metabolizing enzyme: Female predominant expression of human and mouse cytochrome P450 3A isoforms

Journal of Health Science

Volumn 55, Issue 3, 2009, Pages 325-337

  Sakuma, Tsutomu ^a   Kawasaki, Yuki ^a   Jarukamjorn, Kanokwan ^a,b   Nemoto, Nobuo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Cytochrome P450 3A4; Drug metabolizing enzymes; Female sex hormone; Growth hormone; Pregnane X receptor; Sex difference

Indexed keywords

CYTOCHROME P450 1A2; CYTOCHROME P450 2E1; CYTOCHROME P450 3A; DRUG METABOLIZING ENZYME; GROWTH HORMONE; PREGNANE X RECEPTOR;

ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME SPECIFICITY; ENZYME SUBSTRATE; FEMALE; HORMONE RELEASE; HUMAN; MALE; MOUSE; NONHUMAN; PREGNANCY; PROTEIN EXPRESSION; REVIEW; SEX DIFFERENCE; SIGNAL TRANSDUCTION;

RODENTIA;

EID: 66749088074     PISSN: 13449702     EISSN: 13475207     Source Type: Journal    
DOI: 10.1248/jhs.55.325     Document Type: Review

References (88)

1. Harris, R. Z., Benet, L. Z. and Schwartz, J. B. (1995) Gender effects in pharmacokinetics and pharmacodynamics. Drugs, 50, 222-239.
2. Anderson, G. D. (2005a) Sex and racial differences in pharmacological response: where is the evidence? pharmacogenetics, pharmacokinetics, and pharmacodynamics. J. Women's Health, 14, 19-29. (Pubitemid 40309363)
3. Kato, R. and Yamazoe, Y. (1993) Hormonal regulation of cytochrome P450 in rat liver. In Handbook of Experimental Pharmacology, volume 105, Cytochrome P450 (Schenkman, J. B. and Greim, H., Eds.), Springer-Verlag, Berlin, pp. 447-459.
4. Cotreau, M. M., von Moltke, L. L. and Greenblatt, D. J. (2005) The influence of age and sex on the clearance of cytochrome P450 3A substrates. Clin. Pharmacokinet., 44, 33-60. (Pubitemid 40100551)
5. Scandlyn, M. J., Stuart, E. C. and Rosengren, R. J. (2008) Sex-specific differences in CYP450 isoforms in humans. Expert opinion on drug Metabolism & toxicology, 4, 413-424.
6. Lamba, V., Lamba, J., Yasuda, K., Strom, S., Davila, J., Hancock, M. L., Fackenthal, J. D., Rogan, P. K., Ring, B., Wrighton, S. A. and Schuetz, E. G. (2003) Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression. J. Pharmacol. Exp. Ther., 307, 906-922. (Pubitemid 37494207)
7. Nakajima, M., Fukami, T., Yamanaka, H., Higashi, E., Sakai, H., Yoshida, R., Kwon, J. T., McLeod, H. L. and Yokoi, T. (2006) Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations. Clin. Pharmacol Ther., 80, 282-297. (Pubitemid 44313906)
8. Guengerich, F. P. (1999) Cytochrome P-450 3A4: regulation and role in drug metabolism. Annu. Rev. Pharmacol. Toxicol., 39, 1-17. (Pubitemid 29222549)
9. Watkins, P. B., Wrighton, S. A., Schuetz, E. G., Molowa, D.T. and Guzelian, P. S. (1987) Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man. J. Clin. Invest., 80, 1029-1036. (Pubitemid 18075638)
10. Williams, J. A., Hyland, R., Jones, B. C., Smith, D. A., Hurst, S., Goosen, T. C., Peterkin, V., Koup, J. R. and Ball, S. E. (2004) Drug-drug interactions for UDP-glucuronosyltransferase substrates: A pharmacokinetic explanation for typically observed low exposure AUCi/AUC ratios. Drug Metab. Dispos., 32, 1201-1208. (Pubitemid 39410902)
11. Guengerich, F. P., Shimada, T., Yun, C. H., Yamazaki, H., Raney, K. D., Thier, R., Coles, B. and Harris, T. M. (1994) Interactions of ingested food, beverage, and tobacco components involving human cytochrome P4501A2, 2A6, 2E1, and 3A4 enzymes. Environ. Health Perspect., 102 Suppl 9, 49-53.
12. Li, A. P., Kaminski, D. L. and Rasmussen, A. (1995) Substrates of human hepatic cytochrome P450 3A4. Toxicology, 104, 1-8. (Pubitemid 26016371)
13. Kirby, G. M., Wolf, C. R., Neal, G. E., Judah, D. J., Henderson, C. J., Srivatanakul, P. and Wild, C. P. (1993) In vitro metabolism of aflatoxin B1 by normal and tumorous liver tissue from Thailand. Carcinogenesis, 14, 2613-2620. (Pubitemid 24016605)
14. Dally, H., Edler, L., J̈ager, B., Schmezer, P., Spiegelhalder, B., Dienemann, H., Drings, P., Schulz, V., Kayser, K., Bartsch, H. and Risch, A. (2003) The CYP3A4*1B allele increases risk for small cell lung cancer: effect of gender and smoking dose. Pharmacogenetics, 13, 607-618. (Pubitemid 37311147)
15. Keshava, C., McCanlies, E. C. and Weston, A. (2004) CYP3A4 polymorphisms-potential risk factors for breast and prostate cancer: a HuGE review. Am. J. Epidemiol., 160, 825-841. (Pubitemid 39434767)
16. Burk, O. and Wojnowski, L. (2004) Cytochrome P450 3A and their regulation. Naunyn-Schmiedeberg's archives of pharmacology, 369, 105-124. (Pubitemid 38161227)
17. Koch, I., Weil, R., Wolbold, R., Brockm̈oller, J., Hustert, E., Burk, O., Nuessler, A., Neuhaus, P., Eichelbaum, M., Zanger, U. and Wojnowski, L. (2002) Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA. Drug Metab. Dispos., 30, 1108-1114.
18. Niwa, T., Murayama, N., Emoto, C. and Yamazaki, H. (2008) Comparison of kinetic parameters for drug oxidation rates and substrate inhibition potential mediated by cytochrome P450 3A4 and 3A5. Curr. Drug Metab., 9, 20-33.
19. Agarwal, V., Kommaddi, R. P., Valli, K., Ryder, D., Hyde, T. M., Kleinman, J. E., Strobel, H. W. and Ravindranath, V. (2008) Drug metabolism in human brain: high levels of cytochrome P4503A43 in brain and metabolism of anti-anxiety drug alprazolam to its active metabolite. PLoS ONE, 3, e2337.
20. Wolbold, R., Klein, K., Burk, O., Nussler, A. K., Neuhaus, P., Eichelbaum, M., Schwab, M. and Zanger, U. M. (2003) Sex is a major determinant of CYP3A4 expression in human liver. Hepatology, 38, 978-988. (Pubitemid 37221681)
21. Hunt, C. M., Westerkam, W. R. and Stave, G. M. (1992) Effect of age and gender on the activity of human hepatic CYP3A. Biochem. Pharmacol., 44, 275-283.
22. Schmidt, R., Baumann, F., Hanschmann, H., Geissler, F. and Preiss, R. (2001) Gender difference in ifosfamide metabolism by human liver microsomes. Eur. J. Drug Metab. Pharmacokinet., 26, 193-200. (Pubitemid 32988561)
23. Parkinson, A., Mudra, D. R., Johnson, C., Dwyer, A. and Carroll, K. M. (2004) The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Toxicol. Appl. Pharmacol., 199, 193-209. (Pubitemid 39208721)
24. Schirmer, M., Rosenberger, A., Klein, K., Kulle, B., Toliat, M. R., N̈urnberg, P., Zanger, U. M. and Wojnowski, L. (2007) Sex-dependent genetic markers of CYP3A4 expression and activity in human liver microsomes. Pharmacogenomics, 8, 443-453. (Pubitemid 46746352)
25. Schmucker, D. L., Woodhouse, K. W., Wang, R. K., Wynne, H., James, O. F., McManus, M. and Kremers, P. (1990) Effects of age and gender on in vitro properties of human liver microsomal monooxygenases. Clin. Pharmacol. Ther., 48, 365-374. (Pubitemid 20362269)
26. Shimada, T., Yamazaki, H., Mimura, M., Inui, Y. and Guengerich, F. P. (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther., 270, 414-423. (Pubitemid 24229655)
27. George, J., Byth, K. and Farrell, G. C. (1995) Age but not gender selectively affects expression of individual cytochrome P450 proteins in human liver. Biochem. Pharmacol., 50, 727-730.
28. Williams, E. T., Leyk, M., Wrighton, S. A., Davies, P. J., Loose, D. S., Shipley, G. L. and Strobel, H. W. (2004) Estrogen regulation of the cytochrome P450 3A subfamily in humans. J. Pharmacol. Exp. Ther., 311, 728-735. (Pubitemid 39391561)
29. Chen, M., Ma, L., Drusano, G. L., Bertino, J. S., Jr. and Nafziger, A. N. (2006) Sex differences in CYP3A activity using intravenous and oral midazolam. Clin. Pharmacol. Ther., 80, 531-538. (Pubitemid 44737490)
30. Dilger, K., Eckhardt, K., Hofmann, U., Kucher, K., Mikus, G. and Eichelbaum, M. (1999) Chronopharmacology of intravenous and oral modified release verapamil. Br. J. Clin. Pharmacol., 47, 413-419. (Pubitemid 29161274)
31. Krecic-Shepard, M. E., Barnas, C. R., Slimko, J. and Schwartz, J. B. (2000) Faster clearance of sustained release verapamil in men versus women: continuing observations on sex-specific differences after oral administration of verapamil. Clin. Pharmacol. Ther., 68, 286-292.
32. Paine, M. F., Ludington, S. S., Chen, M. L., Stewart, P. W., Huang, S. M. and Watkins, P. B. (2005) Do men and women differ in proximal small intestinal CYP3A or P-glycoprotein expression? Drug Metab. Dispos., 33, 426-433. (Pubitemid 40279944)
33. Wacher, V. J., Wu, C. Y. and Benet, L. Z. (1995) Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol. Carcinog., 13, 129-134.
34. Cummins, C. L., Wu, C.-Y. and Benet, L. Z. (2002) Sex-related differences in the clearance of cytochrome P450 3A substrates may be caused by P-glycoprotein. Clin. Pharmacol. Ther., 72, 474-489. (Pubitemid 36237718)
35. Schuetz, E. G., Furuya, K. N. and Schuetz, J. D. (1995) Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms. J. Pharmacol. Exp. Ther., 275, 1011-1018. (Pubitemid 26023635)
36. Kerlan, V., Dreano, Y., Bercovici, J. P., Beaune, P. H., Floch, H. H. and Berthou, F. (1992) Nature of cytochromes P450 involved in the 2-/4-hydroxylations of estradiol in human liver microsomes. Biochem. Pharmacol., 44, 1745-1756.
37. Kerr, B. M., Thummel, K. E., Wurden, C. J., Klein, S. M., Kroetz, D. L., Gonzalez, F. J. and Levy, R. H. (1994) Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation. Biochem. Pharmacol., 47, 1969-1979. (Pubitemid 24192051)
38. Nakamura, H., Nakasa, H., Ishii, I., Ariyoshi, N., Igarashi, T., Ohmori, S. and Kitada, M. (2002) Effects of endogenous steroids on CYP3A4-mediated drug metabolism by human liver microsomes. Drug Metab. Dispos., 30, 534-540. (Pubitemid 34456975)
39. Mattison, D. and Zajicek, A. (2006) Gaps in knowledge in treating pregnant women. Gender Medicine: official jounal of the Partnership for Gender-Specific Medicine at Columbia University, 3, 169-182. (Pubitemid 44615984)
40. Tracy, T. S., Venkataramanan, R., Glover, D. D. and Caritis, S. N. (2005) Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A4 activity) during pregnancy. Am. J. Obstet. Gynecol., 192, 633-639. (Pubitemid 40215007)
41. Anderson, G. D. (2005b) Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin. Pharmacokinet., 44, 989-1008. (Pubitemid 41356388)
42. Zhang, H., Wu, X., Wang, H., Mikheev, A. M., Mao, Q. and Unadkat, J. D. (2008) Effect of pregnancy on cytochrome P450 3a and P-glycoprotein expression and activity in the mouse: mechanisms, tissue specificity, and time course. Mol. Pharmacol., 74, 714-723.
43. Anakk, S., Ku, C. Y., Vore, M. and Strobel, H. W. (2003) Insights into gender bias: rat cytochrome P450 3A9. J. Pharmacol. Exp. Ther., 305, 703-709. (Pubitemid 36459190)
44. Zhang, Y., Kim, M. J., Bertino, J. S. Jr., Nafziger, A. N. and Sellers, E. M. (2006) Use of omeprazole as a CYP3A probe drug: effect of sex and menstrual cycle phase on CYP3A activity in healthy Caucasian adults. J. Clin. Pharmacol., 46, 345-352. (Pubitemid 43260322)
45. Mathias, A. A., Maggio-Price, L., Lai, Y., Gupta, A. and Unadkat, J. D. (2006) Changes in pharmacokinetics of anti-HIV protease inhibitors during pregnancy: the role of CYP3A and P-glycoprotein. J. Pharmacol. Exp. Ther., 316, 1202-1209. (Pubitemid 43345295)
46. Unadkat, J. D., Wara, D. W., Hughes, M. D., Mathias, A. A., Holland, D. T., Paul, M. E., Connor, J., Huang, S., Nguyen, B. Y., Watts, D. H., Mofenson, L. M., Smith, E., Deutsch, P., Kaiser, K. A. and Tuomala, R. E. (2007) Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant women. Antimicrob. Agents Chemother., 51, 783-786. (Pubitemid 46185308)
47. Mathias, A. A., West, S., Hui, J. and Kearney, B. P. (2009) Dose-response of ritonavir on hepatic CYP3A activity and elvitegravir oral exposure. Clin. Pharmacol. Ther., 85, 64-70.
48. Kosel, B. W., Beckerman, K. P., Hayashi, S., Homma, M. and Aweeka, F. T. (2003) Pharmacokinetic of nelfinavir and indinavir in HIV-1-infected pregnant women. AIDS, 17, 1195-1199. (Pubitemid 36667762)
49. Handschin, C. and Meyer, U. A. (2003) Induction of drug metabolism: the role of nuclear receptors. Pharmacol. Rev., 55, 649-673. (Pubitemid 37504978)
50. Masuyama, H., Suwaki, N., Tateishi, Y., Nakatsukasa, H., Segawa, T. and Hiramatsu, Y. (2005) The pregnane X receptor regulates gene expression in a ligand- and promoter-selective fashion. Mol. Endocrinol., 19, 1170-1180. (Pubitemid 40594117)
51. Dai, D., Bai, R., Hodgson, E. and Rose, R. L. (2001) Cloning, sequencing, heterologous expression, and characterization of murine cytochrome P450 3a25*(Cyp3a25), a testosterone 6beta-hydroxylase. J. Biochem. Mol. Toxicol., 15, 90-99. (Pubitemid 32322057)
52. Sakuma, T., Takai, M., Endo, Y., Kuroiwa, M., Ohara, A., Jarukamjorn, K., Honma, R. and Nemoto, N. (2000) A novel female-specific member of theCYP3A gene subfamily in the mouse liver. Arch. Biochem. Biophys., 377, 153-162. (Pubitemid 30257300)
53. Sakuma, T., Endo, Y., Mashino, M., Kuroiwa, M., Ohara, A., Jarukamjorn, K. and Nemoto, N. (2002) Regulation of the expression of two female-predominant CYP3A mRNAs (CYP3A41 and CYP3A44) in mouse liver by sex and growth hormones. Arch. Biochem. Biophys., 404, 234-242. (Pubitemid 34913554)
54. Masuyama, H., Hiramatsu, Y., Mizutani, Y., Inoshita, H. and Kudo, T. (2001) The expression of pregnane X receptor and its target gene, cytochrome P450 3A1, in perinatal mouse. Mol. Cell. Endocrinol., 172, 47-56. (Pubitemid 32098399)
55. Anakk, S., Huang, W., Staudinger, J. L., Tan, K., Cole, T. J., Moore, D. D. and Strobel, H. W. (2007) Gender dictates the nuclear receptor-mediated regulation of CYP3A44. Drug Metab. Dispos., 35, 36-42. (Pubitemid 46036474)
56. Kawamoto, T., Kakizaki, S., Yoshinari, K. and Negishi, M. (2000) Estrogen activation of the nuclear orphan receptor CAR (constitutive active receptor) in induction of the mouse Cyp2b10 gene. Mol. Endocrinol., 14, 1897-1905.
57. Yamamoto, M., Sakuma, T., Ichimaru, H. and Nemoto, N. (2001) Localization of estradiolresponsive region in the phenobarbital-responsive enhancer module of mouse Cyp2b-10 gene. J. Biochem. Mol. Toxicol., 15, 76-82. (Pubitemid 32322055)
58. Jansson, J. O., Eden, S. and Isaksson, O. (1985) Sexual dimorphism in the control of growth hormone secretion. Endocr. Rev., 6, 128-150.
59. Waxman, D. J., Pampori, N. A., Ram, P. A., Agrawal, A. K. and Shapiro, B. H. (1991) Interpulse interval in circulating growth hormone patterns regulates sexually dimorphic expression of hepatic cytochrome P450. Proc. Natl. Acad. Sci. U.S.A., 88, 6868-6872. (Pubitemid 21915051)
60. MacLeod, J. N., Pampori, N. A. and Shapiro, B. H. (1991) Sex differences in the ultradian pattern of plasma growth hormone concentrations in mice. J. Endocrinol., 131, 395-399.
61. Veldhuis, J. D. and Bowers, C. Y. (2003) Human GH pulsatility: an ensemble property regulated by age and gender. J. Endocrinol. Invest., 26, 799-813. (Pubitemid 38049162)
62. Gatford, K. L., Egan, A. R., Clarke, I. J. and Owens, P. C. (1998) Sexual dimorphism of the somatotrophic axis. J. Endocrinol., 157, 373-389. (Pubitemid 28275837)
63. Jarukamjorn, K., Sakuma, T., Jaruchotikamol, A., Ishino, Y., Oguro, M. and Nemoto, N. (2006) Modified expression of cytochrome P450 mRNAs by growth hormone in mouse liver. Toxicology, 219, 97-105. (Pubitemid 43120710)
64. Sakuma, T., Kitajima, K., Nishiyama, M., Endo, Y., Miyauchi, K., Jarukamjorn, K. and Nemoto, N. (2004) Collaborated regulation of female-specific murine Cyp3a41 gene expression by growth and glucocorticoid hormones. Biochem. Biophys. Res. Commun., 314, 495-500. (Pubitemid 38084745)
65. Sakuma, T., Bhadhprasit, W., Hashita, T. and Nemoto, N. (2008) Synergism of glucocorticoid hormone with growth hormone for female-specific mouse Cyp3a44 gene expression. Drug Metab. Dispos., 36, 878-884.
66. Jaffe, C. A., Turgeon, D. K., Lown, K., Demott-Friberg, R. and Watkins, P. B. (2002) Growth hormone secretion pattern is an independent regulator of growth hormone actions in humans. Am. J. Physiol. Endocrinol. Metab., 283, E1008-E1015. (Pubitemid 35216960)
67. Sinúes, B., Mayayo, E., Fanlo, A., Mayayo, E. Jr., Bernal, M. L., Bocos, P., Bello, E., Labarta, J. I. and Ferŕandez-Lonǵas, A. (2004) Effects of growth hormone deficiency and rhGH replacement therapy on the 6beta-hydroxycortisol/free cortisol ratio, a marker of CYP3A activity, in growth hormone-deficient children. Eur. J. Clin. Pharmacol., 60, 559-564. (Pubitemid 39517908)
68. Watkins, P. B., Turgenon, D. K., Jaffe, C. A., Ho, P. J. and Barkan, A. L. (1993) Pulsation frequency of growth hormone may mediate gender difference in CYP3A activity in man (Abstract). Clin. Res., 41, 132.
69. Matthews, D. R., Hindmarsh, P. C., Pringle, P. J. and Brook, C. G. (1991) A distribution method for analysing the baseline of pulsatile endocrine signals as exemplified by 24-hour growth hormone profiles. Clin. Endocrinol. (Oxf ), 35, 245-252.
70. Dhir, R. N., Dworakowski, W., Tangavel, C. and Shapiro, B. H. (2006) Sexual dimorphic regulation of hepatic isoforms of human cytochrome P450 by growth hormone. J. Pharmacol. Exp. Ther., 316, 87-94. (Pubitemid 41832584)
71. Liddle, C., Goodwin, B. J., George, J., Tapner, M. and Farrell, G. C. (1998) Separate and interactive regulation of cytochrome P450 3A4 by triiodothyronine, dexamethasone, and growth hormone in cultured hepatocytes. J. Clin. Endocrinol. Metab., 83, 2411-2416. (Pubitemid 28503039)
72. Cheung, C., Yu, A.-M., Chen, C.-S., Krausz, K. W., Byrd, L. G., Feigenbaum, L., Edwards, R. J., Waxman, D. J. and Gonzalez, F. J. (2006) Growth hormone determines sexual dimorphism of hepatic cytochrome P450 3A4 expression in transgenic mice. J. Pharmacol. Exp. Ther., 316, 1328-1334. (Pubitemid 43345309)
73. Waxman, D. J. and O'Connor, C. (2006) Growth hormone regulation of sex-dependent liver gene expression. Mol. Endocrinol., 20, 2613-2629. (Pubitemid 44833525)
74. Holloway, M. G., Cui, Y., Laz, E. V., Hosui, A., Hennighausen, L. and Waxman, D. J. (2007) Loss of sexually dimorphic liver gene expression upon hepatocyte-specific deletion of Stat5a-Stat5b locus. Endocrinology, 148, 1977-1986. (Pubitemid 46997034)
75. Sakuma, T., Kitajima, K., Nishiyama, M., Mashino, M., Hashita, T. and Nemoto, N. (2004) Suppression of female-specific murine Cyp2b9 gene expression by growth or glucocorticoid hormones. Biochem. Biophys. Res. Commun., 323, 776-781. (Pubitemid 39243386)
76. Hashita, T., Sakuma, T., Akada, M., Nakajima, A., Yamahara, H., Ito, S., Takesako, H. and Nemoto, N. (2008) Forkhead box A2-mediated regulation of female-predominant expression of the mouse Cyp2b9 gene. Drug Metab. Dispos., 36, 1080-1087.
77. Carter-Su, C., Schwartz, J. and Smit, L. (1996) Molecular mechanism of growth hormone action. Annu. Rev. Physiol., 58, 187-207. (Pubitemid 26106718)
78. Jover, R., Bort, R., Gomez-Lechon, M. J. and Castell, J. V. (2001) Cytochrome P450 regulation by hepatocytes nuclear factor 4 in human hepatocyte: A study using adenovirus-mediated antisense targeting. Hepatology, 33, 668-675. (Pubitemid 32185230)
79. Tirona, R. G., Lee, W., Leake, B. F., Lan, L. B., Cline, C. B., Lamba, V., Parviz, F., Duncan, S. A., Inoue, Y., Gonzalez, F. J., Schuetz, E. G. and Kim, R. (2003) The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4. Nat. Med., 9, 220-224. (Pubitemid 36227725)
80. Matsumura, K., Saito, T., Takahashi, Y., Ozeki, T., Kiyotani, K., Fujieda, M., Yamazaki, H., Kunitoh, H. and Kamataki, T. (2004) Identification of a novel polymorphic enhancer of the human CYP3A4 gene. Mol. Pharmacol., 65, 326-334. (Pubitemid 38134260)
81. Kamiyama, Y., Matsubara, T., Yoshinari, K., Nagata, K., Kamimura, H. and Yamazoe, Y. (2007) Role of human hepatocyte nuclear factor 4α in the expression of drug-metabolizing enzymes and transporters in human hepatocytes assessed by use of small interfering RNA. Drug Metab. Pharmacokinet., 22, 287-298.
82. Wiwi, C. A., Gupte, M. and Waxman, D. J. (2004) Sexually dimorphic P450 gene expression in liver-specific hepatocyte nuclear factor 4-deficient mice. Mol. Endocrinol., 18, 1975-1987. (Pubitemid 39006502)
83. Kamataki, T., Shimada, M., Maeda, K. and Kato, R. (1985) Pituitary regulation of sex-specific forms of cytochrome P-450 in liver microsomes of rats. Biochem. Biophys. Res. Commun., 130, 1247-1253. (Pubitemid 16253373)
84. MacGeoch., C, Morgan, E. T. and Gustafsson, J.-Å. (1985) Hypothalamo-pituitary regulation of cytochrome P-450 15 apoprotein levels in rat liver. Endocrinology, 117, 2085-2092. (Pubitemid 16194265)
85. Sasaki, Y., Takahashi, Y., Nakayama, K. and Kamataki, T. (1999) Cooperative regulation of CYP2C12 gene expression by STAT5 and liver-specific factors in female rats. J. Biol. Chem., 274, 37117-37124. (Pubitemid 30016786)
86. Endo, M., Takahashi, Y., Sasaki, Y., Saito, T. and Kamataki, T. (2005) Novel gender-related regulation of CYP2C12 gene expression in rats. Mol. Endocrinol., 19, 1181-1190. (Pubitemid 40598101)
87. Thangavel, C. and Shapiro, B. H. (2008) Inherent sexually dimorphic expression of hepatic CYP2C12 correlated with repressed activation of growth hormone-regulated signal transduction in male rats. Drug Metab. Dispos., 36, 1884-1895.
88. Thangavel, C. and Shapiro, B. H. (2007) A molecular basis for the sexually dimorphic response to growth hormone. Endocrinology, 148, 2894-2903. (Pubitemid 46984794)